Cargando…
Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy
Despite the biological and therapeutic relevance of CDK4/6 for the treatment of HR+, HER2- advanced breast cancer, the detailed mode of action of CDK4/6 inhibitors is not completely understood. Of particular interest, phosphorylation of CDK4 at T172 (pT172) is critical for generating the active conf...
Autores principales: | Gharbi, Severine Isabelle, Pelletier, Laura A., Espada, Alfonso, Gutiérrez, Jesus, Sanfeliciano, Sonia Maria Gutiérrez, Rauch, Charles T., Ganado, Maria Patricia, Baquero, Carmen, Zapatero, Elisabet, Zhang, Aiping, Benach, Jordi, Russell, Anna-Maria, Cano, Leticia, Gomez, Sandra, Broughton, Howard, Pulliam, Nicholas, Perez, Carmen Maria, Torres, Raquel, Debets, Marjoke F., de Dios, Alfonso, Puig, Oscar, Hilgers, Mark T., Lallena, Maria Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709041/ https://www.ncbi.nlm.nih.gov/pubmed/36446794 http://dx.doi.org/10.1038/s41523-022-00494-y |
Ejemplares similares
-
Author Correction: Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy
por: Gharbi, Severine Isabelle, et al.
Publicado: (2022) -
Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation
por: Torres-Guzmán, Raquel, et al.
Publicado: (2022) -
Preclinical characterization of abemaciclib in hormone receptor positive breast cancer
por: Torres-Guzmán, Raquel, et al.
Publicado: (2017) -
Rapid assessment of conformational preferences in biaryl and aryl carbonyl fragments
por: Gutiérrez Sanfeliciano, Sonia Maria, et al.
Publicado: (2018) -
Abemaciclib for breast cancer
Publicado: (2020)